XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2
CONSOLIDATED AND CONDENSED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
$ in Thousands, shares in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Class A and Class B Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Balance (in shares) at Dec. 31, 2020     100          
Balance at Dec. 31, 2020 $ (1,192,000) $ (631,000) $ 0 $ 699,000 $ (699,000) $ (1,886,000) $ 68,000 $ (5,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 149,000         149,000    
Issuance of common stock upon vesting of RSUs (in shares)     1          
Equity-based compensation expense 167,000     167,000        
Repurchase of common stock (in shares)     (1)          
Repurchase of common stock (300,000)     (300,000)        
Shares issued upon conversion of convertible notes (Note4) (in shares)     4          
Shares issued upon conversion of convertible notes (Note4) 265,000     265,000        
Balance (in shares) at Jun. 30, 2021     104          
Balance at Jun. 30, 2021 (1,542,000)   $ 0 132,000   (1,669,000)   (5,000)
Balance (in shares) at Mar. 31, 2021     104          
Balance at Mar. 31, 2021 (1,470,000)   $ 0 332,000   (1,800,000)   (2,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 131,000         131,000    
Other comprehensive loss (3,000)             (3,000)
Equity-based compensation expense 86,000     86,000        
Repurchase of common stock (in shares)     (1)          
Repurchase of common stock (300,000)     (300,000)        
Shares issued upon conversion of convertible notes (Note4) (in shares)     1          
Shares issued upon conversion of convertible notes (Note4) 14,000     14,000        
Balance (in shares) at Jun. 30, 2021     104          
Balance at Jun. 30, 2021 (1,542,000)   $ 0 132,000   (1,669,000)   (5,000)
Balance (in shares) at Dec. 31, 2021     105          
Balance at Dec. 31, 2021 (1,619,000)   $ 0 337,000   (1,949,000)   (7,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) (697,000)         (697,000)    
Other comprehensive loss (5,000)             (5,000)
Issuance of common stock upon vesting of RSUs (in shares)     2          
Equity-based compensation expense 251,000     251,000        
Repurchase of common stock (in shares)     (1)          
Repurchase of common stock (75,000)     (75,000)        
Balance (in shares) at Jun. 30, 2022     106          
Balance at Jun. 30, 2022 (2,145,000)   $ 0 513,000   (2,646,000)   (12,000)
Balance (in shares) at Mar. 31, 2022     105          
Balance at Mar. 31, 2022 (1,904,000)   $ 0 374,000   (2,268,000)   (10,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) (378,000)         (378,000)    
Other comprehensive loss (2,000)             (2,000)
Issuance of common stock upon vesting of RSUs (in shares)     1          
Equity-based compensation expense 139,000     139,000        
Balance (in shares) at Jun. 30, 2022     106          
Balance at Jun. 30, 2022 $ (2,145,000)   $ 0 $ 513,000   $ (2,646,000)   $ (12,000)